Smartleaf Asset Management
LKFT icon

Smartleaf Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Smartleaf Asset Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7K Hold
360
– – ﹤0.01% 2336
2026
Q1 		$10.4K Sell
360
-29
-7% -$960 ﹤0.01% 2313
2025
Q4 		$12.7K Buy
+389
New +$12.6K ﹤0.01% 2284

Other funds holding LKFT

Gilead Sciences
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
Tang Capital Management
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Madison Avenue Partners
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Prosight Management
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EcoR1 Capital
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
DME Capital Management
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Smartleaf Asset Management's LKFT Position: Q2 2026 in Review

Smartleaf Asset Management held its Lakefront Biotherapeutics American Depositary Shares (LKFT) position steady in Q2 2026 at 360 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2336.

Smartleaf Asset Management first reported a position in LKFT in Q4 2025 and has held it in 3 quarters since. The position peaked at $12.7K in Q4 2025. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Smartleaf Asset Management held 360 shares of Lakefront Biotherapeutics American Depositary Shares worth $10.7K as of Q2 2026.
  • Smartleaf Asset Management left its Lakefront Biotherapeutics American Depositary Shares share count unchanged in Q2 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2336 holding.
  • Smartleaf Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2025 and has held it in 3 quarters since.
  • Smartleaf Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $12.7K in Q4 2025.
  • 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.